Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Abstract CRYO-ROP risk model prediction of retinopathy (RM-ROP) progression from prethreshold (Th) ROP

Go back to Resources

Abstract CRYO-ROP risk model prediction of retinopathy (RM-ROP) progression from prethreshold (Th) ROP

Authors:

Location:

Go back to Resources

Untitled

Go back to Resources

Untitled

Authors:

Location:

Go back to Resources

Timing of retinopathy of prematurity (ROP) events: screening implications

Go back to Resources

Timing of retinopathy of prematurity (ROP) events: screening implications

Authors:

Location:

Go back to Resources

The use of monoclonal therapy in the treatment of intraocular inflammatory disease

Go back to Resources

The use of monoclonal therapy in the treatment of intraocular inflammatory disease

Authors:

Location:

Go back to Resources

The NEI Visual Functioning Questionnaire: experience of the AREDS

Go back to Resources

The NEI Visual Functioning Questionnaire: experience of the AREDS

Authors:

Location:

Go back to Resources

The impact of recombinant human growth hormone treatment during chronic renal insufficiency on renal transplant recipients

Go back to Resources

The impact of recombinant human growth hormone treatment during chronic renal insufficiency on renal transplant recipients

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The development of the National Eye Institute refractive error correction questionnaire (NEI-RECQ), a measure of vision-targeted health-related quality of life

Go back to Resources

The development of the National Eye Institute refractive error correction questionnaire (NEI-RECQ), a measure of vision-targeted health-related quality of life

Authors:

Location:

Go back to Resources

The Cord Blood Transplantation (COBLT) Study: The first two years of recruitment and collection by the COBLT Cord Blood Banks

Go back to Resources

The Cord Blood Transplantation (COBLT) Study: The first two years of recruitment and collection by the COBLT Cord Blood Banks

Authors:

Location:

Go back to Resources

The Age-Related Eye Disease Study: A clinical trial of zinc and antioxidants - Age-Related Eye Disease Study Report No. 2

Go back to Resources

The Age-Related Eye Disease Study: A clinical trial of zinc and antioxidants - Age-Related Eye Disease Study Report No. 2

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 122
  • Page 123
  • Page 124
  • Page 125
  • Current page 126
  • Page 127
  • Page 128
  • Page 129
  • Page 130
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification